Portfolio company
ViewsML
United States · £3.9m raised
Raised
£3.9m
Latest stage
Seed
Rounds recorded
1
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform providing virtual biomarker staining of pathology images for biopharmaceutical researchers, clinical trial teams and diagnostic laboratories.
SourceFunding history · 1
Similar companies
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
Viseur AI
This company develops an artificial intelligence platform for medical imaging and digital pathology workflows to assist healthcare professionals in hospitals and diagnostic laboratories.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Imagenomix
The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.
Spotlight Pathology
This company develops artificial intelligence software for clinicians to analyse digital pathology images for the diagnosis and classification of blood cancers.
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
TileBio
TileBio develops artificial intelligence foundation models for digital pathology to assist clinicians and pharmaceutical companies with cancer diagnosis, biomarker discovery and drug development.
